内皮细胞苹果酸酶1失活缓解肺动脉高压
该研究探讨苹果酸酶1(ME1)在肺动脉高压(PH)中的作用。通过全局及内皮特异性ME1敲除小鼠及ME1抑制剂,发现ME1在PH患者和小鼠肺组织内皮细胞中升高,敲除或抑制ME1可减轻缺氧或SU5416/缺氧诱导的PH,机制涉及促进腺苷生成和A2AR信号。
要点
- 内皮细胞ME1在PH中表达和活性升高,敲除ME1可减轻实验性PH。
- ME1抑制通过促进腺苷生成和A2AR信号改善内皮功能。
- ME1抑制剂在预防和治疗 settings 中均 attenuates PH 进展。
核心结论
- 内皮细胞ME1上调通过负调控腺苷生成导致内皮功能紊乱,在PH发展中起致病作用。
- ME1可能成为上调保护性腺苷信号治疗PH的新药理靶点。
研究设计与样本
- 使用全局和内皮特异性ME1敲除小鼠研究ME1在缺氧和SU5416/缺氧诱导PH中的作用。
- 使用shRNA和ME1酶抑制剂(ME1*)研究肺动脉内皮细胞机制。
- 通过体内代谢组学和体外Seahorse代谢分析识别下游通路。
- 在SuHx诱导PH动物模型中评估ME1*的药理效果。
主要发现
- PH患者和小鼠肺组织中ME1蛋白水平和酶活性高度升高,主要位于血管内皮细胞。
- 全局敲除ME1保护小鼠免于缺氧或SuHx诱导的PH。
- 内皮特异性ME1缺失减轻肺血管重构和PH发展。
- ME1抑制促进腺苷生成,激活A2AR介导的腺苷信号,增加一氧化氮生成并减少促炎分子表达。
- ME1抑制通过调节苹果酸-天冬氨酸NADH穿梭以ATP依赖方式激活腺苷生成,平衡氧化磷酸化和糖酵解。
临床怎么用
- ME1抑制剂可能用于PH治疗,通过促进腺苷生成发挥作用。
- 内皮ME1可作为PH治疗的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pulmonary hypertension (PH) is a progressive cardiopulmonary disease with a high mortality rate. Although growing evidence has revealed the importance of dysregulated energetic metabolism in the pathogenesis of PH, the underlying cellular and molecular mechanisms are not fully understood. In this study, we focused on ME1 (malic enzyme 1), a key enzyme linking glycolysis to the tricarboxylic acid cycle. We aimed to determine the role and mechanistic action of ME1 in PH. METHODS: Global and endothelial-specific ME1 knockout mice were used to investigate the role of ME1 in hypoxia- and SU5416/hypoxia (SuHx)-induced PH. Small hairpin RNA and ME1 enzymatic inhibitor (ME1*) were used to study the mechanism of ME1 in pulmonary artery endothelial cells. Downstream key metabolic pathways and mediators of ME1 were identified by metabolomics analysis in vivo and ME1-mediated energetic alterations were examined by Seahorse metabolic analysis in vitro. The pharmacological effect of ME1* on PH treatment was evaluated in PH animal models induced by SuHx. RESULTS: We found that ME1 protein level and enzymatic activity were highly elevated in lung tissues of patients and mice with PH, primarily in vascular endothelial cells. Global knockout of ME1 protected mice from developing hypoxia- or SuHx-induced PH. Endothelial-specific ME1 deletion similarly attenuated pulmonary vascular remodeling and PH development in mice, suggesting a critical role of endothelial ME1 in PH. Mechanistic studies revealed that ME1 inhibition promoted downstream adenosine production and activated A2AR-mediated adenosine signaling, which leads to an increase in nitric oxide generation and a decrease in proinflammatory molecule expression in endothelial cells. ME1 inhibition activated adenosine production in an ATP-dependent manner through regulating malate-aspartate NADH (nicotinamide adenine dinucleotide plus hydrogen) shuttle and thereby balancing oxidative phosphorylation and glycolysis. Pharmacological inactivation of ME1 attenuated the progression of PH in both preventive and therapeutic settings by promoting adenosine production in vivo. CONCLUSIONS: Our findings indicate that ME1 upregulation in endothelial cells plays a causative role in PH development by negatively regulating adenosine production and subsequently dysregulating endothelial functions. Our findings also suggest that ME1 may represent as a novel pharmacological target for upregulating protective adenosine signaling in PH therapy.
引用
- Luo Y, Qi X, Zhang Z, et al. Inactivation of Malic Enzyme 1 in Endothelial Cells Alleviates Pulmonary Hypertension. Circulation. 2024. PMID: 38314588. doi:10.1161/CIRCULATIONAHA.123.067579
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。